Drugs for the Heart E-Book
Author | : Lionel H. Opie |
Publisher | : Elsevier Health Sciences |
Total Pages | : 513 |
Release | : 2011-12-01 |
ISBN-10 | : 9781455740895 |
ISBN-13 | : 1455740896 |
Rating | : 4/5 (896 Downloads) |
Download or read book Drugs for the Heart E-Book written by Lionel H. Opie and published by Elsevier Health Sciences. This book was released on 2011-12-01 with total page 513 pages. Available in PDF, EPUB and Kindle. Book excerpt: The new edition of this market-leading cardiac drug resource equips you with the latest advances in cardiovascular pharmacology, one of the most rapidly changing areas of medicine. It not only offers in-depth information on all of the drug classes used to treat heart disease, but also covers new drug classes, drug use for single and multiple problem management, and more. Dynamic full-color drawings illustrate key pharmacological and physiological actions, and a user-friendly organization directs you to the information you need. An increased emphasis on the practical use of drugs saves you valuable time in researching relevant information. Features the practice-proven experience of two well-known editors who represent the best possible combination of clinical and research expertise in cardiovascular therapeutics. Offers easy-to-access, useful information on when to use each drug—and for what conditions—in a chapter entitled “Which Drug for Which Disease. Discusses the management of single diseases and multiple comorbidities. Summarizes each drug class at the end of chapters to expedite reference. Incorporates all-new drugs, preparations, and clinical trial data in each chapter, equipping you to make the most up-to-date, informed clinical decisions. Offers expanded coverage of comorbid diseases through new chapters on metabolic syndrome, hyperglycemia, and diabetes. Features an increased emphasis on the practical use of drugs through highlighted sections and key illustrations, saving you time in searching for relevant information. Presents the work of several new contributors who represent a broad international perspective to equip you with a global view of cardiovascular pharmacology.